Revolution Medicines (RVMD) Common Equity (2019 - 2026)
Revolution Medicines' Common Equity came in at $2.61 billion for Q2 2026, up 39.7% from $1.87 billion a year earlier and up 73.8% from the prior quarter.
Powered by 
Analysis
Revolution Medicines (RVMD) Common Equity (2019 - 2026) Analysis & Trends
At the end of FY2025, Revolution Medicines' Common Equity was $1.63 billion, down 28.0% from FY2024.
- Common Equity carries a five-year compound annual growth rate of 28.0% (FY2020 to FY2025).
- Going back by year, Common Equity was $2.27 billion in FY2024 (+24.0%), $1.83 billion in FY2023 (+166.5%), $685.19 million in FY2022 (+13.7%) and $602.57 million in FY2021 (+26.9%).
- The Q2 2026 figure represents the highest quarterly Common Equity in data going back to Q1 2019.
- Year-over-year, Common Equity increased in six of the last eight quarters, with growth averaging 16.6%.
- The fastest year-over-year change in Common Equity over five years came in Q4 2023 (growth of 166.5%), and the weakest in Q4 2025 (a decline of 28.0%).
- Business Quant data shows RVMD's Common Equity at $1.5 billion (Q1 2026), $1.63 billion (Q4 2025) and $1.6 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 84.97 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 85.49 Bn |
| 10 | Revolution Medicines | 37.70 Bn | 27.90 Bn | - | 2.61 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.61 Bn |
| Mar 31, 2026 | 1.50 Bn |
| Dec 31, 2025 | 1.63 Bn |
| Sep 30, 2025 | 1.60 Bn |
| Jun 30, 2025 | 1.87 Bn |
| Mar 31, 2025 | 2.08 Bn |
| Dec 31, 2024 | 2.27 Bn |
| Sep 30, 2024 | 1.57 Bn |
| Jun 30, 2024 | 1.62 Bn |
| Mar 31, 2024 | 1.73 Bn |
| Dec 31, 2023 | 1.83 Bn |
| Sep 30, 2023 | 837.46 Mn |
| Jun 30, 2023 | 930.84 Mn |
| Mar 31, 2023 | 952.22 Mn |
| Dec 31, 2022 | 685.19 Mn |
| Sep 30, 2022 | 681.42 Mn |
| Jun 30, 2022 | 498.84 Mn |
| Mar 31, 2022 | 550.99 Mn |
| Dec 31, 2021 | 602.57 Mn |
| Sep 30, 2021 | 638.20 Mn |
API Access
Revolution Medicines Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=RVMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "RVMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=RVMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();